@LemanBiotech profile picture
Leman Biotech @LemanBiotech

Leman Biotech is a clinical-stage biotech company focusing on developing innovative cancer immunotherapies using our unique metabolic reprogramming technology

Joined March 2023
  • Tweets 4
  • Following 5
  • Followers 50
Photos and videos
Leman Biotech retweeted
Li Tang@Tang_Lab_EPFL
29 Jun 2023
Leman Biotech, a spin-off of my lab at EPFL, has successfully treated the first patient using its metabolically enhanced CD19 CAR-T therapy. The patient has achieved complete remission (NCT05715606)@LemanBiotech @EPFL_BioE @EPFLEngineering @EPFL_en linkedin.com/posts/leman-bio…

Leman Biotech's Novel CD19 CAR-T Shows Great Promise in Low-Dose Treatment of Patients with...

Leman Biotech is pleased to announce the successful treatment of the first patient with recurrent or refractory diffuse large B-cell lymphoma using our metabolically enhanced CD19 CAR-T therapy, Meta...

linkedin.com
9
6
117
7,943
Leman Biotech retweeted
EPFL School of Engineering@EPFLEngineering
20 Mar 2023
After a 3-year pandemic break, @EPFL_en's #EngineeringIndustryDay enjoyed a successful 4th edition on 8/3, when academics & entrepreneurs converged to tackle #Energy & #Materials, #HealthTech, #Manufacturing & #Robotics, & #IntelligentSystems! actu.epfl.ch/news/engineerin… @EPFL_Park
6
22
2,779
Our metabolic reprogramming technology revitalizes terminally exhausted T cells, restores their proliferative capacity and killing power, ultimately leads to a cure of cancer. It has shown great therapeutic potential and safety in animal tumor models. swissinfo.ch/eng/business/sw…

Swiss cancer research could ‘boost’ immunotherapy

Swiss researchers have made major advances in cancer immunotherapy but bringing these to patients faces challenges.

swissinfo.ch
1
5
377
@Tang_Lab_EPFL @startupEPFL @BiopoleLausanne
155
Load more